Wei Guo

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Chronic Myeloid Leukemia

Neoadjuvant Chemotherapy

Top Venues

Cell death discovery

APL bioengineering

This page only lists publications with an associated author ORCID identifier.

Publications

Cheng-Long Chen, Shidong Wang, Juan Wang, Fang-Zhou Yao, Xiaodong Tang, Wei Guo
Nanosized drug delivery strategies in osteosarcoma chemotherapy. APL bioengineering 7 (1) (2023)
Cheng-Long Chen, Shidong Wang, Juan Wang, Fang-Zhou Yao, Xiaodong Tang, Wei Guo
Nanosized drug delivery strategies in osteosarcoma chemotherapy. APL bioengineering 7 (1) (2023)
Cheng-Long Chen, Qianyu Shi, Jiuhui Xu, Tingting Ren, Yi Huang, Wei Guo
Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma. Cell death discovery 8 (1) (2022)
Cheng-Long Chen, Qianyu Shi, Jiuhui Xu, Tingting Ren, Yi Huang, Wei Guo
Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma. Cell death discovery 8 (1) (2022)
Cheng-Long Chen, Qianyu Shi, Jiuhui Xu, Tingting Ren, Yi Huang, Wei Guo
Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma. Cell death discovery 8 (1) (2022)
Cheng-Long Chen, Qianyu Shi, Jiuhui Xu, Tingting Ren, Yi Huang, Wei Guo
Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma. Cell death discovery 8 (1) (2022)